ATE141795T1 - Feste, stabilisierte arzneimittelform von choline-metall-carboxymethylzellulose-salicylat enthaltenden zusammensetzungen - Google Patents
Feste, stabilisierte arzneimittelform von choline-metall-carboxymethylzellulose-salicylat enthaltenden zusammensetzungenInfo
- Publication number
- ATE141795T1 ATE141795T1 AT92110049T AT92110049T ATE141795T1 AT E141795 T1 ATE141795 T1 AT E141795T1 AT 92110049 T AT92110049 T AT 92110049T AT 92110049 T AT92110049 T AT 92110049T AT E141795 T1 ATE141795 T1 AT E141795T1
- Authority
- AT
- Austria
- Prior art keywords
- salicylate
- metal
- solid
- carboxymethyl cellulose
- compositions containing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229960001860 salicylate Drugs 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 3
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 3
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000003248 quinolines Chemical group 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/716,547 US5217965A (en) | 1991-06-17 | 1991-06-17 | Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE141795T1 true ATE141795T1 (de) | 1996-09-15 |
Family
ID=24878446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92110049T ATE141795T1 (de) | 1991-06-17 | 1992-06-15 | Feste, stabilisierte arzneimittelform von choline-metall-carboxymethylzellulose-salicylat enthaltenden zusammensetzungen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5217965A (de) |
| EP (1) | EP0519371B1 (de) |
| AT (1) | ATE141795T1 (de) |
| AU (1) | AU645205B2 (de) |
| CA (1) | CA2071262C (de) |
| DE (1) | DE69213113T2 (de) |
| DK (1) | DK0519371T3 (de) |
| ES (1) | ES2093740T4 (de) |
| GR (1) | GR3021831T3 (de) |
| IE (1) | IE921943A1 (de) |
| ZA (1) | ZA924002B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
| US7282217B1 (en) | 2003-08-29 | 2007-10-16 | Kv Pharmaceutical Company | Rapidly disintegrable tablets |
| US9744191B2 (en) | 2012-03-19 | 2017-08-29 | Yale University | Antimicrobial compositions and methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3636200A (en) * | 1969-06-09 | 1972-01-18 | Hoffmann La Roche | Pharmaceutical suspension |
| US4067974A (en) * | 1976-01-21 | 1978-01-10 | The Purdue Frederick Company | Stabilized solid form choline salicylate compositions |
| CA1070299A (en) * | 1976-01-21 | 1980-01-22 | Ernest J. Sasmor | Stabilized solid form choline salicylate compositions |
| US4747881A (en) * | 1985-02-05 | 1988-05-31 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
| GB8629567D0 (en) * | 1986-12-10 | 1987-01-21 | Boots Co Plc | Therapeutic agents |
| US5043168A (en) * | 1990-04-26 | 1991-08-27 | Sidmak Laboratories, Inc. | Solid choline magnesium salicylate composition and method of preparing same |
-
1991
- 1991-06-17 US US07/716,547 patent/US5217965A/en not_active Expired - Lifetime
-
1992
- 1992-05-29 AU AU17309/92A patent/AU645205B2/en not_active Ceased
- 1992-06-02 ZA ZA924002A patent/ZA924002B/xx unknown
- 1992-06-15 DK DK92110049.1T patent/DK0519371T3/da active
- 1992-06-15 ES ES92110049T patent/ES2093740T4/es not_active Expired - Lifetime
- 1992-06-15 CA CA002071262A patent/CA2071262C/en not_active Expired - Fee Related
- 1992-06-15 EP EP92110049A patent/EP0519371B1/de not_active Expired - Lifetime
- 1992-06-15 AT AT92110049T patent/ATE141795T1/de not_active IP Right Cessation
- 1992-06-15 DE DE69213113T patent/DE69213113T2/de not_active Expired - Fee Related
- 1992-07-01 IE IE194392A patent/IE921943A1/en not_active IP Right Cessation
-
1996
- 1996-11-28 GR GR960403223T patent/GR3021831T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2093740T3 (es) | 1997-01-01 |
| ES2093740T4 (es) | 1997-03-16 |
| EP0519371B1 (de) | 1996-08-28 |
| DE69213113T2 (de) | 1997-03-13 |
| AU645205B2 (en) | 1994-01-06 |
| CA2071262C (en) | 1998-02-03 |
| DE69213113D1 (de) | 1996-10-02 |
| US5217965A (en) | 1993-06-08 |
| GR3021831T3 (en) | 1997-02-28 |
| EP0519371A1 (de) | 1992-12-23 |
| DK0519371T3 (da) | 1996-09-16 |
| ZA924002B (en) | 1993-02-24 |
| CA2071262A1 (en) | 1992-12-18 |
| IE921943A1 (en) | 1992-12-30 |
| AU1730992A (en) | 1992-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8303531D0 (sv) | Farmaceutisk komposition | |
| LV10954A (lv) | Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija | |
| ATE95035T1 (de) | Erythrit enthaltende kaugummizusammensetzung. | |
| KR850000975A (ko) | 발프로익산과 그 염의 혼합물을 토대로 한 조성물 | |
| IL104943A0 (en) | Xanthine derivatives and pharmaceutical compositions containing the same | |
| ATE38834T1 (de) | 5-substituierte 1,2,4-oxadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE154011T1 (de) | Inhibitoren der calciumaufnahme | |
| FR2354091A1 (fr) | Utilisation d'esters aliphatiques d'acide 2-methyl-2-alkylalcanoiques comme matieres aromatiques et compositions de parfums en contenant | |
| BR8904205A (pt) | Composicao de resina poliacetal resistente as intemperies | |
| SE8404065D0 (sv) | Novel biologically active compounds | |
| KR850002396A (ko) | 모발처리용 조성물 | |
| SE8100104L (sv) | Farmaceutiska kompositioner | |
| ATE141795T1 (de) | Feste, stabilisierte arzneimittelform von choline-metall-carboxymethylzellulose-salicylat enthaltenden zusammensetzungen | |
| SE8600658D0 (sv) | Novel composition of matter | |
| FR2490491B1 (fr) | Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application | |
| DK0394022T3 (da) | Calciumpantothenatkomposition | |
| IT1251226B (it) | Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego | |
| NO178286C (no) | Fremgangsmåte ved fremstilling av et topisk farmasöytisk preparat inneholdende 1 | |
| FI803704A7 (fi) | Heterosyklinen yhdiste ja sen synteesi, sitä sisältävät farmaseuttiset koostumukset ja yhdisteiden ja koostumukoostumusten käyttö lääketieteessä. | |
| JPS5726587A (en) | Stabilization of ascorbic acid oxidase | |
| GB2258397A (en) | Pharmaceutical compositions containing amethocaine | |
| DE69112747D1 (de) | Inhibitoren der Calciumaufnahme. | |
| ATE24716T1 (de) | Lenkotrien-antagonisten. | |
| ATE53004T1 (de) | Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen. | |
| JPS6468319A (en) | Anti-inflammatory |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |